Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00842751 · ClinicalTrials.gov registry record · Phase 2
Oral T7 Oral Testosterone in Man
A Phase 2 study, sponsored by University of Washington.
- Completed
- Registry status
- Phase 2
- Development phase
- 11
- Enrollment target
NCT00842751: Completed Phase 2 study, sponsored by University of Washington.
NCT00842751 is a Phase 2 study that has completed, run by University of Washington. The registered enrollment target is 11 participants, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (92% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00842751, a Phase 2 study, has completed, sponsored by University of Washington.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 11 participants
- Enrollment target
Study Summary
The purpose of this study is to test how the body absorbs and processes new forms of oral testosterone. Information gained during the study may help develop better forms of testosterone therapy in the future.
Primary Outcome
Area under the curve of serum testosterone Pharmacokinetic measures time-weighted mean concentration calculated as area under the concentration curve (AUC) divided by time from initiation of dosing for the morning dose and corrected for differences in baseline hormone concentration.
Interventions
- DRUG First Intervention (7 days)
- OTHER First Washout (7 days)
- DRUG Second Intervention (7 days)
- DRUG Third Intervention (7 days)
- OTHER Second wash-out period
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 11 participants |
| Start Date | 2009-07 |
| Est. Completion | 2009-12 |
| Phase | Phase 2 |
What the finished NCT00842751 record still lists
NCT00842751 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 11 participants, a relatively small participant target, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (92% lower).
The record links to 0 conditions, and to 5 interventions - of which First Intervention (7 days) is the first listed.
NCT00842751 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00842751 about?
NCT00842751 is a clinical study titled "Oral T7 Oral Testosterone in Man". The purpose of this study is to test how the body absorbs and processes new forms of oral testosterone. Information gained during the study may help develop better forms of testosterone therapy in the future.
What is the current status of trial NCT00842751?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 11 participants. The study started on 2009-07. Estimated completion is 2009-12.
What interventions are being tested in trial NCT00842751?
The interventions under investigation include: First Intervention (7 days) (DRUG), First Washout (7 days) (OTHER), Second Intervention (7 days) (DRUG), Third Intervention (7 days) (DRUG), Second wash-out period (OTHER).
Who is sponsoring clinical trial NCT00842751?
This trial is sponsored by University of Washington, which has 1,048 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00842751's enrollment target sits among peer trials
11 1967th of 2000 higher than 33 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03114462 · 11 participants · Phase 1
Trial of Stereotactic HYpofractionateD RadioAblative (HYDRA) Treatment of Laryngeal Cancer
- NCT06039709 · 11 participants · Phase 1
Sonodynamic Therapy in Patients With Recurrent GBM
- NCT06425380 · 11 participants · NA
Pilot Open-Label Trial of Resistant Potato Starch in Patients With Cirrhosis and Overt Hepatic Encephalopathy
- NCT06472661 · 11 participants · Early Phase 1
FUSA With Intratumoral PolyICLC in Regionally Advanced Resectable Melanoma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia